Hermetica Superfood Encyclopedia
Kuzu (Pueraria lobata) is a Japanese root used in traditional Kampo medicine containing bioactive isoflavones including puerarin, daidzin, and daidzein. Despite traditional use, no clinical trials have established specific health benefits in humans.
Kuzu (kudzu) is derived from the root of Pueraria lobata, a climbing vine native to East Asia, particularly China, Japan, and Korea. The rhizome or root is processed into extracts and powders through methods including 60-70% ethanol reflux extraction, ultrasonic extraction with methanol-water mixtures, or enzymatic hydrolysis.
The research dossier provides no human clinical trials, RCTs, or meta-analyses for Pueraria lobata. All available research focuses exclusively on extraction methods and analytical chemistry rather than clinical efficacy or health outcomes.
No clinically studied dosage ranges are available as no human trials are reported in the research. Extraction yields of 2.09% isoflavones via 70% ethanol extraction are noted, but without corresponding therapeutic dosing data. Consult a healthcare provider before starting any new supplement.
Kuzu contains isoflavones including puerarin (primary compound), daidzin, and daidzein that exhibit weak estrogenic activity through estrogen receptor interactions. These compounds may influence antioxidant pathways and inflammatory mediator expression. The root starch also provides prebiotic fibers that may affect gut microbiome composition.
Currently, no human clinical trials exist evaluating kuzu's health effects or efficacy for specific conditions. Research is limited to laboratory and animal studies examining isolated isoflavone compounds. Traditional Chinese medicine references kuzu as 'gegen' but without documented clinical validation. The absence of human trials means therapeutic benefits remain unsubstantiated by modern evidence standards.
Kuzu is generally considered safe when consumed as a food ingredient in traditional preparations. The isoflavone content may theoretically interact with hormone-sensitive conditions or medications due to mild estrogenic activity. Pregnant and breastfeeding women should exercise caution due to lack of safety data. No specific drug interactions or adverse effects have been documented in clinical literature.